Kyrgyzstan tracks 109 million medicine packages via digital system

Kyrgyzstan is advancing the digitalization of its pharmaceutical and medical device supply chain, with a state information system now tracking approximately 109.2 million packages. This initiative, spearheaded by the Ministry of Health, aims to provide digital oversight of key processes, from a product's entry into the country and registration through to its final delivery to consumers.

Currently, 2,604 participants are connected to the system, including 291 medical organizations and 2,313 pharmacies. The system has registered 2,075 types of medicinal products. A key component is the mobile application "Dary-Darmek," designed to bolster patient safety, counteract the circulation of counterfeit medicines, and increase transparency within the pharmaceutical market.

As of June 30, 2026, Kyrgyzstan's state registry listed 11,074 pharmaceutical products. Of these, around 6,300 are medications, with 570 (9.1%) being domestically produced. The registry also includes 4,800 medical devices, of which 90 (2%) are manufactured in Kyrgyzstan. This marks a slight increase in local production, though the country still relies heavily on imports, with up to 95% of medicines being imported from other nations previously reported.

The digitalization effort is a significant step towards modernizing healthcare infrastructure and ensuring the integrity of the drug supply chain in Kyrgyzstan. The Ministry of Health reports that the system effectively monitors the entire lifecycle of pharmaceutical products, contributing to a more secure and transparent market.